Trial intelligence / Profile preview

Evaluation of different doses of midazolam for amnesia and sedation in general anesthesia

IRCT201101293468N5Phase 2Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of midazolam in amnesia, sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Sedation level and Amnesia effect. Started Apr 2010; status: completed.

02

Drugs

midazolam
03

Conditions

amnesia

Beyond the preview

Go deeper on IRCT201101293468N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201101293468N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call